Bacteriology-Hygiene, F Paris, France. Université Pierre et Marie Curie-Paris 6,
|
|
- Lynn Brown
- 6 years ago
- Views:
Transcription
1 JCM Accepts, published online ahead of print on 25 September 2013 J. Clin. Microbiol. doi: /jcm Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Evaluation of LACTA test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae Aurélie Renvoisé 1**, Dominique Decré 2,3**, Rishma Amarsy-Guerle 4, Te-Din Huang 5, Christelle Jost 3, Isabelle Podglajen 5, Laurent Raskine 4, Nathalie Genel 2, Pierre Bogaerts 5, Vincent Jarlier 1 and Guillaume Arlet 2,3,7 * Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Laboratory of Bacteriology-Hygiene, F Paris, France. Université Pierre et Marie Curie-Paris 6, Laboratory of Bacteriology-Hygiene, F Paris, France. 2 Université Pierre et Marie Curie-Paris 6, Medical School, Département of Bactériology, F Paris, France 3 Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Department of Bacteriology, F Paris, France 4 Assistance Publique-Hôpitaux de Paris, Hôpital Lariboisière, Laboratory of Bacteriology- Virology-Hygiene, F-75010, Paris, France 5 Université Catholique de Louvain, CHU de Mont-Godinne, Laboratory of Bacteriology, 5530 Yvoir, Belgium 6 Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Microbiologie, F-7515, Paris, France 7 Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Department of Bacteriology, F , Paris, France * Corresponding author: guillaume.arlet@tnn.aphp.fr ** AR and DD contributed equally to this work 25 1
2 Running title: Rapid detection of 3GC resistance in Enterobacteriaceae Key words: rapid, diagnostic test, third-generation cephalosporins, resistance, Enterobacteriaceae, extended-spectrum beta-lactamase, point-of-care 29 2
3 Abstract Since decades, third-generation cephalosporins (3GC) are major drugs to treat infections due to Enterobacteriaceae; growing resistance to these antibiotics makes important to rapidly detect such resistance. LACTA test is a chromogenic test developed for detecting within 15 minutes 3GC-resistant isolates from cultures on solid media. A multicenter prospective study conducted in 5 French and Belgian hospitals evaluated the performances of this test on clinical isolates. Based on antibiotic susceptibility testing, strains resistant or intermediate to cefotaxime or ceftazidime were classified as 3GC-resistant and molecular characterization of this resistance was performed. The rate of 3GC-resistance was globally 13.9% (332/2387), 9.4% in Escherichia coli (132/1403), 25.6% in Klebsiella pneumoniae (84/328), 30.3% in species naturally producing inducible AmpC beta-lactamases (109/360), and 5.6% in Klebsiella oxytoca and Citrobacter koseri (7/124). The overall sensitivity and specificity of LACTA test were 87.7% and 99.6% respectively, were 96 and 100% for E. coli and K. pneumoniae and were 67.4% and 99.6% for species naturally producing inducible AmpC beta-lactamase. False negative results were mainly related to 3GC-resistant strains producing AmpC beta-lactamase. Interestingly, the test was positive for all 3GC-resistant extended-spectrum beta-lactamase producing isolates (n=241). Positive predictive value was 97% and would remain 96% for prevalence of 3GC-resistance ranging between 10 and 30%. Negative predictive value was 99% for E. coli and K. pneumoniae and 89% for the species producing inducible AmpC beta-lactamase. In conclusion βlacta test was found to be easy to use and efficient to predict resistance to third-generation cephalosporins, particularly in extended-spectrum betalactamase producing strains. 3
4 Introduction Enterobacteriaceae are one of the most important causes of community and nosocomial acquired infections (1;2). Beta-lactams (mainly extended-spectrum cephalosporins and carbapenems) are widely used to treat such infections (1). However resistance to these molecules has been reported increasingly worldwide and represents a major public health issue. The EARS-net data ( in 2011 reported various rates of resistance to third-generation cephalosporins (3GC) for Escherichia coli: from 3% of strains in Sweden to 36.2% in Cyprus, 6% in Belgium and 8.2% in France; and for Klebsiella pneumoniae: from 2.3% of strains in Sweden to 81% in Bulgaria, 13.6% in Belgium and 25.3% in France. Enzymatic resistance to these molecules is related to extendedspectrum beta-lactamases (ESBL), but also to overproduced chromosomal or acquired AmpC beta-lactamases, and to carbapenemases. ESBL-producing Enterobacteriaceae are of growing concern among nosocomial and community-acquired infections (1). Although ESBL producers should not be reported anymore as resistant to all 3GC and aztreonam, even when the strains appear susceptible according to standard breakpoints (3), rapid detection of ESBL producing Enterobacteriaceae is still needed to prompt the implementation of isolation procedures to prevent crosstransmission to other patients and to initiate appropriate antibiotic therapy (4). The detection of beta-lactamases conferring resistance to 3GC is necessary to avoid inappropriate antibiotic use, since multiple studies in a wide range of clinical settings, clinical syndromes, and organisms have shown that failure or delay in adequate therapy results in an adverse mortality outcome (2). For bacteremia, ESBL production was associated with severe adverse outcomes, including higher overall and infection-related mortality, increased length of stay, delay in appropriate therapy, discharge to chronic care and higher costs (5). 4
5 Several phenotypic methods have been proposed for ESBL detection on isolated Enterobacteriaceae strains. The double disk synergy test, the combination disk method and the ESBL Etests have been developed (6). Sensitivities and specificities for these two tests range from 80% to 95% (7;8). Automated phenotypic methods have also been developed (VITEK2 ESBL test, Biomérieux, Marcy l'etoile, France; Phoenix ESBL test, Becton Dickinson, Sparks, MD, USA); they are based on the simultaneous assessment of the antibacterial activity of extended-spectrum cephalosporins, measured alone or in the presence of clavulanate (6). The performances of these systems varied depending upon the species investigated, showing higher sensitivity (80 to 99%) than specificity (50 to 80%) (6-8). Molecular tests for ESBL detection (9)(10)(2) have been developed to reduce time to reporting, but their cost and the need of an experimented staff limit their use. Moreover the observation of new ESBL has limited the interest for these techniques regarding their limited ability to cover the whole range of variants. MALDI-TOF mass spectrometry was recently proposed to detect antibiotic resistance mechanisms (11), but is to date not reliable enough for routine diagnosis (12;13). A new chromogenic test called LACTA test (BLT, Bio-Rad, Marnes-la-Coquette, France) was recently developed for rapid detection (in less than 15 minutes) of Enterobacteriaceae resistant to 3GC from culture on solid media. Preliminary results suggested that this test is reliable for the detection of 3GC resistant Enterobacteriaceae (14). The test was recently evaluated in Pseudomonas aeruginosa to detect resistance to ceftazidime, and was found sensitive (95%) and specific (87%) for this purpose (15). Here we report the result of a prospective multicenter study aiming at evaluating the performances of the BLT to rapidly detect resistance to 3GC in clinical isolates of Enterobacteriaceae Materials and methods 5
6 Strains. The strains included in the study were consecutive unselected non duplicate strains of Enterobacteriaceae prospectively isolated in 2012 during a period of three months in five different clinical laboratories of French and Belgian teaching hospitals (Figure S1) from clinical specimens of any origins (i.e. not including rectal swabs sampled for systematic screening of multi-resistant bacteria carriers). BLT was performed on primary cultures (or on the first subculture for positive blood cultures) whatever the type of agar medium used, except Mac Conkey agar which is not recommended by the manufacturer. Identification at the species level was performed by MALDI-TOF mass spectrometry analysis or by API 20E system (Biomérieux, Marcy l'etoile, France). βlacta test (BLT). The principle of BLT is based on the cleavage of a chromogenic substrate, HMRZ-86 (chromogenic cephalosporin). This substrate, initially yellow, turns to the red colour when hydrolyzed. The very efficient beta-lactamases hydrolysing HMRZ-86 are ESBL (CTX-M), and carbapenemases (IMP), whereas the activity of overproduced or acquired AmpC is lower (16). In contrast, HMRZ-86 is not hydrolyzed by broad-spectrum beta-lactamases (e.g. SHV-1, TEM-1) or by basal production of AmpC (17). Results were interpreted as recommended by the manufacturer (Bio-Rad, Marnes-la-Coquette, France) both within the first 2 minutes and after 15 minutes, as positive (if colour turned to red or purple) or negative (if colour remained yellow). Results were considered as noninterpretable if the colour turned into orange. Antibiotic susceptibility testing. Antibiotic susceptibility testing (AST) by disk diffusion method was performed the same day as the BLT. AST was performed and interpreted according to CA-SFM 2012 guidelines (inoculum 0.5 McFarland, diluted to 1/10) in the French laboratories (3). The Belgian laboratory (CHU Mont-Godinne, Yvoir, Belgium) used CLSI 2012 guidelines (inoculum 0.5 McFarland) (18). The strains showing intermediate or full resistance were considered together as resistant. For further comparison with BLT, the 6
7 strains were classified into two groups based on AST results: strains resistant to cefotaxime (CTX) and/or ceftazidime (CAZ) have been defined as 3GC resistant (3GC-R) and strains fully susceptible to CTX and CAZ have been defined as 3GC susceptible (3GC-S). Molecular characterization of beta-lactamases. Beta-lactamases conferring resistance to 3GC were detected by molecular methods for: (a) the strains resistant to 3GC, (b) the strains with discrepant results between BLT and AST, and (c) the strains with noninterpretable results of BLT. DNA preparation and multiplex PCRs, previously developed to detect the most frequent widespread genes encoding the OXA-1-like broad-spectrum betalactamases, ESBL, plasmid-mediated AmpC beta-lactamases and class A, B and D carbapenemases, were performed as described (19;20). PCR products were purified using the ExoSap purification kit (Illustra, Exostar 1-step, D. Dutscher, Brumath, France) and bidirectional sequencing was performed using BigDye terminator 3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA, USA). Each sequence was aligned using Applied Biosystems SeqScape software v2.7 and then compared with already known beta-lactamase gene sequences by multiple sequence alignment using the BLAST program on Genbank database. For the species naturally producing inducible AmpC (i.e. Enterobacter spp., Serratia spp., Morganella spp., Providencia spp., and Citrobacter freundii), the strains (i) resistant to 3GC and aztreonam but susceptible to cefepime, carbapenems and (ii) with a negative synergy test between 3GC, cefepime or aztreonam and clavulanic acid, were considered as stably producing derepressed AmpC and not producing ESBL (7;21;22) and were not submitted to molecular characterization. Statistic analysis. Performances for BLT were calculated using SISA website ( A width of 95% was chosen for confidence interval. 7
8 Results Characteristics of the strains. A total of 2,387 strains of Enterobacteriaceae were included in the study: 1,403 of E. coli, 328 of K. pneumoniae, 360 of species naturally producing inducible AmpC beta-lactamases (Enterobacter spp., Morganella spp., Providencia spp., Serratia spp., C. freundii ), 172 of P. mirabilis and 124 of species other than K. pneumoniae naturally producing chromosomal class A enzymes inhibited by clavulanic acid (K. oxytoca and C. koseri) (Table 1). Strains were obtained from 1,717 (72%) urines, 238 (10%) skin and soft tissues specimens, 218 (9%) respiratory specimens, 57 (2%) blood cultures, and 157 (7%) various clinical samples. Strains were collected from the following agar media (Bio-Rad, France and Biomérieux, France): 1,447 from Uriselect 4 agar, 282 from Drigalski agar, 250 from CLED agar, 235 from blood agar, 152 from trypticase soy agar, and 21 from chocolate agar. Based on AST, the overall rate of resistance to 3GC was 13.9% (332/2,387), more specifically 9.4% (132/1,403) in E. coli, 25.6% (84/328) in K. pneumoniae, 30.3% (109/360) in species naturally producing inducible AmpC, 0% (0/172) in P. mirabilis, and 5.6% (7/124) in K. oxytoca and C. koseri (Table 1). Results of molecular characterization of beta-lactamases were as follow. ESBLs were found in 114/1,403 E. coli (8.1%) as follows: 105 CTX-M (including 47 CTX-M-15), 4 SHV (-2, -12) and 5 TEM (-15, -19, -24, -52) enzymes; in 77/328 K. pneumoniae (23.5%): 66 CTX-M (including 61 CTX-M-15), 7 SHV (-2, -5, -12) and 4 TEM (-3, -24, -52) enzymes; in 1/172 P. mirabilis (0.6%), CTX-M-15; in 4/124 K. oxytoca and C. koseri (3.2%): 1 CTX-M- 1, 1 SHV (-12) and 2 TEM (-24, -29) enzymes; and in 46/360 species naturally producing inducible AmpC (12.8%): 28 CTX-M (including 26 CTX-M-15), 15 SHV (-12) and 3 TEM (-11, -24) enzymes (Table 1 and Figure S1). Detailed characterization of ESBL enzymes in 8
9 each center is given in Figure S1. Overall, the proportion of CTX-M-15 among ESBLs was 55.8% (135/242). For the global panel of strains, plasmidic AmpC beta-lactamases were found in 7/1,403 E. coli (6 CMY-2 and 1 DHA-1) and in 7/328 K. pneumoniae (7 DHA-1). No carbapenemase producing strain was detected during the study. Few strains of K. pneumoniae (n=2) and K. oxytoca (n=5), for which BLT yielded discrepant or non interpretable results, were neither producing ESBL nor plasmidic AmpC beta-lactamase, and were considered as overproducing their natural chromosomal beta-lactamase (Table 3) (21;22). Among 109 3GC-R strains of species that naturally produce inducible AmpC, 65 were considered as stably overexpressing this enzyme based on AST (Table 1). Performances of the βlacta test. Resistance to 3GC based on AST results was taken as the gold standard. Consequently, results were considered concordant if 3GC-R strains yielded a positive BLT or if 3GC-S strains yielded a negative BLT. Results were considered discordant in the other cases. Overall, non-interpretable results were observed for 2.4% (57/2,387) of the strains, including 1.4% (20/1,403) in E. coli, 1.8% (6/328) in K. pneumoniae, 0% (0/172) in P. mirabilis, 7.2% (26/360) in species naturally producing inducible AmpC beta-lactamases and 4% (5/124) in K. oxytoca and C. koseri (Table 3). These non-interpretable results were excluded from the concordance analysis. Overall, BLT sensitivity was 87.7% and specificity was 99.6%. Considering each group of species, sensitivity and specificity were 96% and 99.9% for E. coli, 96.3% and 100% for K. pneumoniae, 67.4% and 99.6% for species naturally producing inducible AmpC betalactamases, 100% and 95.5% for K. oxytoca and C. koseri (Table 2). For P. mirabilis (no 3GC resistant strain) specificity was 99.4%. The 8 false positive results observed among the 2,028 3GC-S strains (with interpretable BLT result) included 5 K. oxytoca with a high-level expression of their natural chromosomal enzyme, which were resistant to aztreonam but susceptible to cefotaxime and ceftazidime, 1 CTX-M-15 producing P. mirabilis still 9
10 susceptible to 3GC, 1 wild type P. vulgaris, and 1 OXA-1 producing E. coli (Table 3). The 37 false-negative results observed among the 302 3GC-R strains (with interpretable BLT result) included 29 strains overexpressing AmpC beta-lactamases in the species that naturally produce this enzyme, 5 strains producing plasmidic AmpC beta-lactamases (2 CMY-2 producing E. coli and 3 DHA-1 producing K. pneumoniae) and 3 strains of E. coli that did not produce ESBL nor plasmidic AmpC beta-lactamase but that were 3GC-R at low level (Table 3). Importantly, all the ESBL producing strains of the 3GC-R group (n=241), including 114 E. coli, 77 K. pneumoniae, 46 various species naturally producing inducible AmpC betalactamases and 4 others (K. oxytoca and C. koseri), were detected as resistant by BLT (Table 1) Discussion BLT, designed to rapidly detect 3GC resistant Enterobacteriaceae isolates, was evaluated on a large set of 2,387 strains prospectively collected in clinical practice during a period of 3 months in 5 teaching hospitals. Compared to routine AST, BLT yielded high specificity, both globally (99.6%) and for each group of species, e.g. 99.9% for E. coli, 100% for K. pneumoniae and 99.6% for species naturally producing inducible AmpC beta-lactamases (Table 2). Sensitivity of BLT was high for E. coli and K. pneumoniae (96%) but lower for the species naturally producing inducible chromosomal AmpC beta-lactamase (67.4%). Interestingly, the proportion of non interpretable results was very low (2.4%) suggesting the test operational in routine practice. False positive results were mainly found in strains producing enzymes known to partly inactivate 3GC, but these strains were classified as 3GC susceptible based on recent guidelines used to interpret AST (3). Positive BLT were found for K. oxytoca isolates with a 10
11 high-level expression of their natural chromosomally encoded beta-lactamase, as expected and previously reported by Livermore et al. (17), and one P. mirabilis producing CTX-M-15 enzyme was positive using BLT as expected (16;17). In fact, these results are in agreement with some authors who discourage the use of beta-lactamases substrate drugs as therapy (4). The positive predictive value (PPV) of BLT (97%) calculated in this study based on a 14% prevalence of 3GC resistance in Enterobacteriaceae, will remain high in settings with other prevalence rates (e.g. 96%, 98%, and 99% when such prevalence is 10%, 20%, or 30%, respectively). Consequently, the test can predict accurately when 3GC should be excluded from empiric antibiotic treatment for these two major species, several hours or one day before the results of antibiotic susceptibility testing. Sensitivity was high for the two major species of Enterobacteriaceae, i.e. 96% for E. coli and 96.3% for K. pneumoniae. This performance led to high negative predictive values (NPV) for both species, i.e. 99% in the present study where the prevalence of resistance to 3GC were 9.4% and 25.6%, respectively. NPV will remain high within these 2 species even in epidemiological situations where the prevalence of resistance is much higher, e.g. 98% or 97% for prevalences of 30% or 40%. However, due to lower sensitivity of BLT to detect 3GC resistant Enterobacter spp. and Serratia spp. through AmpC stable overproduction (because of lower affinity and activity of hyperproduced AmpC to hydrolyse HMRZ-86 (16)), the NPV was 89% for these species. The overall NPV of 98% in the present study will decrease if the proportion of this latter group among Enterobacteriaceae is higher. However, the place of these opportunistic species of Enterobacteriaceae is generally limited even in nosocomial situation (e.g. 4 to 7% for Enterobacter spp. depending on the sites of infection (23)). Interestingly, all the 3GC resistant ESBL-producing strains of Enterobacteriaceae were found positive using BLT (n=241), a result that became available within minutes (in less than 2 minutes for 167 isolates (69%)). Consequently, BLT is an excellent test to detect 3GC- 11
12 R Enterobacteriaceae through ESBL production, especially useful in countries where ESBL prevalence is high. In Europe, the proportion of ESBL strains among 3GC-R E. coli and K. pneumoniae is high, ranging from 65 to 100% and 60 to 100%, respectively, depending on the country, based on ECDC 2012 data (23). The test could help to avoid the use of last line antibiotics such as carbapenems in case of negative test. Some remarks on the present results need to be addressed. First, there was no carbapenemase-producing strains in the panel, as expected considering that these organisms are still rare in France as in most European countries (23). However, the spread of carbapenemase-producing Enterobacteriaceae in some countries would justify accurate and rapid tests to detect such strains in addition to 3GC resistant strains (24). Second, the evaluation of the test on P. mirabilis must be held with caution, since no P. mirabilis classified as resistant to 3GC was included in the present study. However 3GC resistance in this species is generally uncommon. Third, the test was evaluated in teaching hospitals with high prevalence of resistant strains. In situation of prevalence of 3GC resistance below 10% (e.g. in some community settings), the PPV could be somewhat lower, e.g. 92% for 5% prevalence of resistance. Last, the study found 2.4% non-interpretable results, mainly in species naturally producing inducible AmpC beta-lactamases (Enterobacter spp. ) (Table 3). Non-interpretable results could limit the interest of BLT in situation of higher prevalence of such species. Nordmann et al have recently proposed a test to specifically detect ESBL producing- Enterobacteriaceae (the ESBL NDP test), relying upon the hydrolysis of the beta-lactam ring of cefotaxime that is inhibited when tazobactam is added to evidence the inhibition of ESBL activity (25). ESBL NDP test was retrospectively evaluated on a collection of 255 strains (from various clinical and geographical origins and previously characterized at the molecular level). The test showed in the published study a specificity of 100% but a sensitivity of 12
13 %, missing part of ESBL producing-strains. In the present study, the sensitivity of BLT to detect 3GC-R through ESBL production was 100% as assessed prospectively on 241 consecutive unselected producing strains. Compared to ESBL NDP test, BLT is a commercial test, is less time-consuming (2-15 vs 60 ) and less staff-demanding (1 step vs 2 steps) (25). Moreover, BLT is designed to detect more widely 3GC resistance, a pragmatic endpoint for therapeutical purpose. In conclusion, BLT was proved to be reliable (i) to accurately predict susceptibility to 3GC when the test is negative, and (ii) to accurately predict resistance to 3GC in E. coli and K. pneumoniae when the test is positive, but less accurately in species such as Enterobacter spp. and Serratia spp.. The test is simple to use and could be implemented in laboratories working for general practitioners since 3GC resistance is emerging in E. coli in the community setting, mainly in relation with the spread of ESBLs (2). In the future, studies evaluating the use of BLT directly from specimens (such as urines) in a point-of-care strategy (26) could lead to even reduce further the delay for therapeutical choice Acknowledgements. Reagents for the βlacta test were provided by Bio-Rad Laboratories, Marnes-la-Coquette, France. We thank Caroline Dallenne and Manette Juvin for their support throughout the study
14 References 1. Coque TM, Baquero F, Canton R 2008 Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13: Pitout JD, Laupland KB 2008 Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: Bonnet R, Caron F, Cavallo J, Chardon H, Chidiac CCP, Drugeon H, Dubreuil L, Jarlier V, Jehl F, Lambert T, Leclercq R, Nicolas-Chanoine MH, Plesiat P, Ploy MC, Quentin C, Soussy C, Varon E, Weber P 2012 Comité de l'antibiogramme de la sociéte française de microbiologie Recommandations Livermore DM, Andrews JM, Hawkey PM, Ho PL, Keness Y, Doi Y, Paterson D, Woodford N 2012 Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother 67: Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y 2006 Clinical and economic impact of bacteremia with extended- spectrumbeta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50: Drieux L, Brossier F, Sougakoff W, Jarlier V 2008 Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 14: Garrec H, Drieux-Rouzet L, Golmard JL, Jarlier V, Robert J 2011 Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. J Clin Microbiol 49: Gazin M, Paasch F, Goossens H, Malhotra-Kumar S 2012 Current trends in culture-based and molecular detection of extended-spectrum-beta-lactamaseharboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 50: Nijhuis RH, van Zwet AA, Savelkoul PH, Roovers EA, Bosboom RW, Postma B, van Griethuysen AJ 2011 Distribution of extended-spectrum beta-lactamase genes using a commercial DNA micro-array system. J Hosp Infect 79: Ellem J, Partridge SR, Iredell JR 2011 Efficient direct extended-spectrum betalactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers. J Clin Microbiol 49: Hrabak J, Chudackova E, Walkova R 2013 Matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin Microbiol Rev 26:
15 Schaumann R, Knoop N, Genzel GH, Losensky K, Rosenkranz C, Stingu CS, Schellenberger W, Rodloff AC, Eschrich K 2012 A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med Sci Monit 18:MT71-MT Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M 2012 Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against beta-lactam antibiotics. J Clin Microbiol 50: Ben Soltana M, Dallenne C, Birgy A, Compain F, Verdet C, Vimont S, Favier C, Juvin M, Arlet G 2012 Evaluation of a new chromogenic test (betalacta test) for rapid detection of third-generation cephalosporins nonsusceptible Enterobacteriaceae. Poster session 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). 15. Laurent T, Huang TD, Bogaerts P, Glupczynski Y 2013 Evaluation of the betalacta test, a novel commercial chromogenic test for rapid detection of ceftazidime non-susceptible Pseudomonas aeruginosa isolates. J Clin Microbiol 51: Hanaki H, Koide Y, Yamazaki H, Kubo R, Nakano T, Atsuda K, Sunakawa K 2007 Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). J Infect Chemother 13: Livermore DM, Warner M, Mushtaq S 2007 Evaluation of the chromogenic Cicabeta-Test for detecting extended-spectrum, AmpC and metallo-betalactamases. J Antimicrob Chemother 60: Cockerill FR, III, Wikler MA, Alder J, Dudley MN, Eliopoulos G, Ferraro MJ, Hardy DJ, Hecht DW, Hindler JA, Patel JB, Powell M, Swenson JM, Thomson BJ, Traczewski MM, Turnidge JD, Weinstein MP, Zimmer BL 2012 CLSI Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement., 32 ed. 19. Dallenne C, Da Costa A, Decre D, Favier C, Arlet G 2010 Development of a set of multiplex PCR assays for the detection of genes encoding important betalactamases in Enterobacteriaceae. J Antimicrob Chemother 65: Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Philippon A, Arlet G 2004 Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48: Courvalin P, Leclercq R, Rice LB 2010 Antibiogram. ESKA. 22. Livermore DM 1995 beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8: ECDC 2012 Annual Epidemiological Report. 15
16 Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V 2012 Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 18: Nordmann P, Dortet L, Poirel L 2012 Rapid detection of extended-spectrum-betalactamase-producing Enterobacteriaceae. J Clin Microbiol 50: Cohen-Bacrie S, Ninove L, Nougairede A, Charrel R, Richet H, Minodier P, Badiaga S, Noel G, La Scola B, De Lamballerie X, Drancourt M, Raoult D 2011 Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. PLoS One 6:e
17 Table 1. Characteristics of the strains included in the study; mechanisms of resistance to third-generation cephalosporins (3GC) and results of ßLACTA TM. Mechanisms of resistance to 3GC Species No. of strains No. of 3GC-R a strains (%.) ESBL Plasmidic AmpC betalactamase CTX-M SHV TEM DHA-1 CMY-2 AmpC stable overproduction Other Escherichia coli (9.4%) a,b Klebsiella pneumoniae c (25.6%) a,b Enterobacter spp. Morganella spp. Serratia spp. Providencia spp. Citrobacter freundii c (30.3%) d 0 Proteus mirabilis (0%) Citrobacter koseri Klebsiella oxytoca (5.6%) e Total c (13.9%) No of strains with ßLACTA TM c a strains intermediate or resistant to ceftazidime or cefotaxime b not producing ESBL nor plasmidic AmpC c three strains (1 K. pneumoniae and 2 Enterobacter spp) produced two distinct beta-lactamases, each of them counted twice in the columns mechanisms of resistance d based on AST (see text for definition) e high level expression of chromosomal KOXY type enzyme
18 Table 2. Performances of the LACTA test for detecting resistance to third-generation cephalosporins; non interpretable results (n = 57, see text for definition) were excluded. LACTA Susceptibility testing % (95 CI) c 3GC-R a 3GC-S b Total Sensitivity Specificity All strains Positive ( ) 99.6 ( ) Negative Total E. coli Positive ( ) 99.9 ( ) Negative Total K. pneumoniae Positive ( ) 100 ( ) Negative Total P. mirabilis Positive (CI not applicable) Negative Total Species naturally producing inducible AmpC beta-lactamase Positive ( ) 99.6 ( ) Negative Total K. oxytoca and C. koseri Positive ( ) 95.5 ( ) Negative Total a strains intermediate or resistant to ceftazidime or cefotaxime b strains fully susceptible to ceftazidime and cefotaxime c CI, confidence interval
19 Table 3. Detailed characterization of strains with false-positive, false-negative, or non-interpretable results.* False positive results (n=8) E. coli 1 strain producing OXA-1 P. vulgaris 1 wild type strain K. oxytoca 5 strains with a high-level expression of chromosomal beta-lactamase P. mirabilis 1 strain producing CTX-M-15 susceptible to 3GC False negative results (n=37) E. coli 2 strains producing plasmidic AmpC beta-lactamase (CMY-2) 3 strains not producing ESBL nor plasmidic AmpC K. pneumoniae 3 strains producing plasmidic AmpC beta-lactamase (DHA-1) Species naturally producing inducible AmpC ** 29 strains overexpressing chromosomal AmpC beta-lactamase * Non-interpretable results among 3GC-R strains (n=30) Non-interpretable results among 3GC-S strains (n=27) E. coli 3 strains producing plasmidic AmpC beta-lactamase (CMY-2) K. pneumoniae 5 strains not producing ESBL nor plasmidic AmpC 1 strain with a high-level expression of chromosomal beta-lactamase 1 strain not producing ESBL nor plasmidic AmpC Species naturally producing inducible AmpC ** 20 strains overexpressing chromosomal AmpC beta-lactamase * E. coli 5 strains producing OXA-1 K. pneumoniae Species naturally producing inducible AmpC 7 strains not producing ESBL nor plasmidic AmpC 1 strain not producing ESBL nor plasmidic AmpC 1 strain with a high-level expression of chromosomal beta-lactamase 1 strain producing OXA-1 1 strain producing plasmidic AmpC beta-lactamase (DHA-1) 6 wild type strains K. oxytoca 4 wild type strains C. koseri 1 wild type strain * see text for definition ** Enterobacter spp., Serratia spp.
Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011
JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1965 1969 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.00203-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Comparative
More informationCarbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.
JCM Accepts, published online ahead of print on 7 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02878-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Carbapenem Disks
More informationDetection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry
JCM Accepts, published online ahead of print on 2 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.01002-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12
More informationRapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures
ORIGINAL ARTICLE BACTERIOLOGY Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures L. Dortet 1,L.Brechard 1, L. Poirel 1,2 and P. Nordmann 1,2 1) Service de Bacteriologie-Virologie,
More informationEmergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Sophie Vaux, Anne Carbonne, Jean-Michel Thiolet, Vincent Jarlier, Bruno Coignard, the RAISIN and Expert Laboratories Group
More informationβ CARBA Test Rapid detection of carbapenemase-producing Enterobacteriaceae strains Contents 1. INTENDED USE
β CARBA Test 25 68260 Rapid detection of carbapenemase-producing Enterobacteriaceae strains 881159 2015/05 Contents 1. INTENDED USE 2. SUMMARY AND EXPLANATION OF THE TEST 3. PRINCIPLE OF THE PROCEDURE
More informationDetermining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing
AAC Accepted Manuscript Posted Online 8 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00838-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 1 2 Determining the
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014.
Annual survey of extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae, 2013 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research
More informationScreening and detection of carbapenemases
Screening and detection of carbapenemases For many isolates with carbapenemases the MICs of carbapenems are around the susceptible breakpoint making resistance difficult to detect - particularly with automated
More informationA new diagnostic microarray (Check-KPC ESBL) for detection and. identification of extended-spectrum beta-lactamases in highly resistant
JCM Accepts, published online ahead of print on 8 June 2011 J. Clin. Microbiol. doi:10.1128/jcm.02087-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationDevelopment of a phenotypic method for fecal carriage detection of OXA-48-producing
JCM Accepts, published online ahead of print on 11 May 2011 J. Clin. Microbiol. doi:10.1128/jcm.00055-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella
ALERT Clinical microbiology considerations related to the emergence of New Delhi metallo beta lactamases (NDM 1) and Klebsiella pneumoniae carbapenemases (KPC) amongst hospitalized patients in South Africa
More informationSurveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia
Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 41 41 Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia IRINA
More informationRapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann
Rapid identification of emerging resistance in Gram negatives Prof. Patrice Nordmann Emerging Resistance threats, CDC USA-2013 Enterobacteriaceae producing extendedspectrum β-lactamases (ESBL) Multi-resistant
More informationPerformance of chromid ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum b-lactamases
Journal of Medical Microbiology (2008), 57, 310 315 DOI 10.1099/jmm.0.47625-0 Performance of chromid ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum b-lactamases
More informationEnterobacteriaceae in Bamako, Mali. Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, CHU Reims, UFR Médecine
AAC Accepts, published online ahead of print on 31 August 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.00675-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationPrevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
More informationOvercoming the PosESBLities of Enterobacteriaceae Resistance
Overcoming the PosESBLities of Enterobacteriaceae Resistance Review of current treatment options Jamie Reed, PharmD Pharmacy Grand Rounds August 28, 2018 Rochester, MN 2018 MFMER slide-1 Disclosure No
More informationbreakpoints, cephalosporins, CLSI, Enterobacteriacae, EUCAST, review Clin Microbiol Infect 2008; 14 (Suppl. 1):
REVIEW Breakpoints for intravenously used cephalosporins in Enterobacteriaceae EUCAST and CLSI breakpoints G. Kahlmeter Department of Clinical Microbiology, Central Hospital, Växjö, Sweden ABSTRACT It
More informationUse of Faropenem as an Indicator of Carbapenemase Activity
JCM Accepts, published online ahead of print on 10 April 2013 J. Clin. Microbiol. doi:10.1128/jcm.00720-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Use of Faropenem as
More informationPublic Health Surveillance for Multi Drug Resistant Organisms in Orange County
Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action
More informationPhenotypic detection of ESBLs and carbapenemases
Phenotypic detection of ESBLs and carbapenemases Standardized susceptibility testing residential workshop 2016 Katie Hopkins PhD Clinical Scientist Antimicrobial Resistance and Healthcare Associated Infections
More informationAbstract. Introduction. Editor: R. Canton
ORIGINAL ARTICLE BACTERIOLOGY A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry,
More informationAcademic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE
Academic Perspective in Emerging No, we can t Issues treat of carbapenemase Resistance and ESBL in Gram-ve producers Bacteria based on MIC David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic
More informationCAT Critically Appraised Topic
CAT Critically Appraised Topic Part I: Evaluation of Three Different Agar Media for Rapid Detection of Extended- Spectrum β-lactamase Producing Enterobacteriaceae from Clinical Screening Samples. Part
More informationDiscussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category
Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide
More informationCephalosporin MIC Distribution of Extended-Spectrum- -Lactamaseand pampc-producing Escherichia coli and Klebsiella Species
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2009, p. 2419 2425 Vol. 47, No. 8 0095-1137/09/$08.00 0 doi:10.1128/jcm.00508-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Cephalosporin
More informationClinical Microbiology Newsletter
Clinical Microbiology Newsletter $88 Vol. 30, No. 10 www.cmnewsletter.com May 15, 2008 Newer β-lactamases: Clinical and Laboratory Implications, Part I * Ellen Smith Moland, B.S.M.T., Soo-Young Kim, M.D.,
More informationSpread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory
Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Olga Perovic*, Ashika Singh-Moodley, Samantha Iyaloo 5 th November
More informationStrains characterization Testing procedure of commercial carbapenemase detection assays
JCM Accepted Manuscript Posted Online 7 December 2016 J. Clin. Microbiol. doi:10.1128/jcm.01853-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. Comparative evaluation of four
More informationEmergence of non-kpc carbapenemases: NDM and more
Emergence of non-kpc carbapenemases: NDM and more --- David Livermore Health Protection Agency, UK The first acquired carbapenemase to be recognised in gram-negative bacteria was IMP-1, a metallo-type,
More informationRevised AAC Short Form format. Comparison of two phenotypic algorithms to detect carbapenemaseproducing
AAC Accepted Manuscript Posted Online 12 June 2017 Antimicrob. Agents Chemother. doi:10.1128/aac.00796-17 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 Revised AAC-00796-17
More informationJOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p. 2575 2579 Vol. 36, No. 9 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Can Results Obtained with Commercially
More informationRevised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in
AAC Accepts, published online ahead of print on 3 December 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01180-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationImpact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test
Published in which should be cited to refer to this work. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test Carbapenem
More informationNONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN
NONFERMENTING GRAM NEGATIVE RODS April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic limitations to assessing carbapenem resistance in nonfermenting GNRs Discuss antimicrobial
More informationDetecting carbapenemases in Enterobacteriaceae
Detecting carbapenemases in Enterobacteriaceae David Livermore Health Protection Agency, Colindale, London 12 August 2003 Mechanisms of carbapenem R in Enterobacteria Impermeability + AmpC or ESBL Metallo
More informationChapter 2. Detection of ESBL producing Enterobacteriaceae
Chapter 2 Detection of ESBL producing Enterobacteriaceae Chapter 1 22 Chapter 2.1 Laboratory detection of extended-spectrum β-lactamase-producing Enterobacteriaceae: evaluation of two screening agar plates
More informationMolecular characterisation of CTX-M-type extendedspectrum β-lactamases of Escherichia coli isolated from a Portuguese University Hospital
EJHP Science Volume 17 2011 Issue 3 P. 1-5 2011 Pharma Publishing and Media Europe. All rights reserved 1781-7595 25 www.ejhp.eu Molecular characterisation of CTX-M-type extendedspectrum β-lactamases of
More informationDifferentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test
Original article: Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test Manish Bansal 1, Nitya Vyas 2, Babita Sharma 3, R.K.Maheshwari 4 1PG Resident, 2 Professor, 3 Assistant
More informationEducational Workshops 2016
Educational Workshops 2016 Keynote CPE Screening We are grateful to Dr Andrew Dodgson, Consultant Microbiologist, Public Health England and Central Manchester Hospitals NHS Foundation Trust Terminology
More informationInsert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J
Insert for Kit 98006/98010/98015 KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J DATE OF ISSUE: 09.02.2017 LANGUAGE: English FOR IN VITRO DIAGNOSTIC
More informationExpert rules in antimicrobial susceptibility testing: State of the art
Expert rules in antimicrobial susceptibility testing: State of the art ESCMID Postgraduate Education Course Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic Hospital Universitario
More informationEUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance
EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance Version 2.0 1 July 2017 1 Based on version 1.0 from December 2013 by the
More informationHaut Conseil de la santé publique - French High Council for Public Health OPINION
Haut Conseil de la santé publique - French High Council for Public Health OPINION Additional information regarding the measures to control the spread of emergent highly-resistant bacteria (ehrb) recommended
More informationMALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility
MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility Sören Schubert, MD Max von Pettenkofer-Institut Ludwig-Maximilians-University (LMU) Munich, Germany Learning Objectives After this presentation,
More informationGuidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011
Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review
More informationResults and experience of BARN ESBL project. Marina Ivanova and project team Tallinn
Results and experience of BARN ESBL project Marina Ivanova and project team Tallinn 13.05.2013 Aim of the project Improvement of detection and surveillance of resistance caused by extended spectrum betalactamase
More informationSensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase
JCM Accepts, published online ahead of print on 19 October 2011 J. Clin. Microbiol. doi:10.1128/jcm.05602-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationDetection of Carbapenem Resistant Enterobacteriacae from Clinical Isolates
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 5 (2016) pp. 864-869 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.505.089
More informationCefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationjmb Research Article Review Semi Kim 1, Ji Youn Sung 2, Hye Hyun Cho 3, Kye Chul Kwon 1, and Sun Hoe Koo 1 *
J. Microbiol. Biotechnol. (2014), 24(6), 765 770 http://dx.doi.org/10.4014/jmb.1306.06036 Review Research Article jmb Characterization of CTX-M-14- and CTX-M-15-Producing Escherichia coli and Klebsiella
More informationMHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions
MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions Dr. Andrew Walkty Medical Microbiologist, Diagnostic Services Manitoba (DSM) June. 17,
More informationExpert rules. for Gram-negatives
Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University
More informationCarbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School
Carbapenemases in Enterobacteriaceae: 2012 Prof P. Nordmann Bicêtre hospital, South-Paris Med School March 21, 2012 Trends in Molecular Medecine NDM IMP OXA-48 KPC VIM ALERT VI M KPC KPC NDM I MP OXA-
More informationIn-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.342
More informationUpdate on CLSI and EUCAST
Update on CLSI and EUCAST 1 Completed work» Cephalosporin breakpoints for Enterobacteriaceae ESBL screens MIC versus resistance mechanism» Carbapenem breakpoints for Enterobacteriaceae Modified Hodge Test»
More informationCARBAPENEMASE PRODUCING ENTEROBACTERIACEAE
CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE Veroniek Saegeman Veroniek Saegeman UZLeuven Carbapenemase producing Enterobacteriaceae (CPE) Introduction on antibiotic resistance Classification of ß-lactamases
More informationEpidemiology of ESBL in hospitals and in the community
Epidemiology of ESBL in hospitals and in the community Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L C Y M R
More informationIn Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated
AAC Accepted Manuscript Posted Online 21 November 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01820-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10
More informationReporting blood culture results to clinicians: MIC, resistance mechanisms, both?
Reporting blood culture results to clinicians: MIC, resistance mechanisms, both? Christian G. Giske, MD, PhD Senior Consultant Physician/Associate Professor Department of Clinical Microbiology Karolinska
More informationMulticenter study of the prevalence and the resistance mechanisms of carbapenem-resistant Enterobacteriaceae (CPE) in Belgium in
Multicenter study of the prevalence and the resistance mechanisms of carbapenem-resistant Enterobacteriaceae (CPE) in Belgium in 2011-2012 Study conducted by: 1. National Reference Center (NRC) for ESBL-producing
More informationEVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS
Indian Journal of Medical Microbiology, (2005) 23 (2):120-124 Brief Communication EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS S Singhal, T
More informationCefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the
More informationMethodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa
Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa Y. Glupczynski Laboratoire de bactériologie Cliniques Universitaires UCL de Mont-Godinne Université Catholique
More information#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore
AAC Accepts, published online ahead of print on 21 October 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01754-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Title: Escherichia
More informationSupplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System
Supplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System Supplementary Material and Methods Characterization of isolates by the
More informationDetecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method?
Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method? Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown
More informationInternational transfer of NDM-1-producing Klebsiella. pneumoniae from Iraq to France
AAC Accepts, published online ahead of print on 18 January 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.01761-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationDiagnosis of CPE: time to throw away those agar plates? Jon Otter, PhD FRCPath Guy s and St. Thomas NHS Foundation Trust / King s College London
Diagnosis of CPE: time to throw away those agar plates? Jon Otter, PhD FRCPath Guy s and St. Thomas NHS Foundation Trust / King s College London Disclosures I am employed part-time by Bioquell I have research
More informationThe Public Health Benefit of CRE Colonization Testing
The Public Health Benefit of CRE Colonization Testing Allison C Brown, PhD MPH Team Lead, AR Capacities and Special Studies Division of Healthcare Quality Promotion CDC Carbapenem Resistance Serious threat
More informationCOMMENTARY. Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues. Kenneth S. Thomson*
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2010, p. 1019 1025 Vol. 48, No. 4 0095-1137/10/$12.00 doi:10.1128/jcm.00219-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. COMMENTARY
More informationEvaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms
ORIGINAL ARTICLE Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms Julie Creighton and Hui Wang Canterbury Health Laboratories, Christchurch ABSTRACT
More informationStandardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland
Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland Version 1.0 7 June 2017 Revision Date June 2018 Scottish Microbiology and Virology Network (SMVN) SMVN Standardisation
More informationAffinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED
AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationDownloaded from ismj.bpums.ac.ir at 10: on Friday March 8th 2019
- ( ) - * :... (MDR) (ESBLs: Extended-Spectrum Beta Lactamases). :.. (CLSI:Clinical and Laboratory Standards Institute). ESBL. combined disk method ESBL : / / / / / B / ( /). / / combined disk method.
More informationRapid identification and resistance assessment: The future is mass spectrometry
Rapid identification and resistance assessment: The future is mass spectrometry Dr Sanmarié Schlebusch Director of Microbiology Mater Pathology Brisbane Outline Introduction Plug and play Pre-prep and
More informationFrequency of Occurrence and Antimicrobial Susceptibility of Bacteria from ICU Patients with Pneumonia
Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria from ICU Patients with Pneumonia Helio S. Sader, M.D.* Mariana Castanheira, Ph.D. Rodrigo E. Mendes, Ph.D. Robert K. Flamm, Ph.D. JMI
More informationMALDI TOF MS based carbapenemase detection from culture isolates and from positive blood culture vials
Ghebremedhin et al. Ann Clin Microbiol Antimicrob (2016) 15:5 DOI 10.1186/s12941-016-0120-x Annals of Clinical Microbiology and Antimicrobials RESEARCH Open Access MALDI TOF MS based carbapenemase detection
More informationDistribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran
African Journal of Microbiology Research Vol. 6(26), pp. 5433-5439, 12 July, 2012 Available online at http://www.academicjournals.org/ajmr DOI: 10.5897/AJMR11.017 ISSN 1996-0808 2012 Academic Journals
More informationSensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the
JCM Accepts, published online ahead of print on 20 August 2014 J. Clin. Microbiol. doi:10.1128/jcm.02369-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Sensitivity of Surveillance
More informationFirst Clinical Cases of OXA-48 Producing Carbapenem Resistant Klebsiella pneumoniae in
JCM Accepts, published online ahead of print on 21 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02580-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10
More informationEmergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH
Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.
More informationIdentification and screening of carbapenemase-producing Enterobacteriaceae
REVIEW 10.1111/j.1469-0691.2012.03815.x Identification and screening of carbapenemase-producing Enterobacteriaceae P. Nordmann 1, M. Gniadkowski 2, C. G. Giske 3, L. Poirel 1, N. Woodford 4, V. Miriagou
More informationNew Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection
New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection Stephen G. Jenkins, PhD, F(AAM), D(ABMM) Professor of Pathology and Laboratory Medicine Professor of Pathology in Medicine
More informationESCMID Online Lecture Library. by author
www.eucast.org EXPERT RULES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA Departamento de Microbiología II Universidad
More informationCeftazidime-Avibactam and Aztreonam an interesting strategy to Overcome β- Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae
AAC Accepted Manuscript Posted Online 19 June 2017 Antimicrob. Agents Chemother. doi:10.1128/aac.01008-17 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 3 Ceftazidime-Avibactam
More informationJournal of Infectious Diseases and
Journal of Infectious Diseases & Therapy ISSN: 2332-0877 Journal of Infectious Diseases and Therapy Santanirand et al., J Infect Dis Ther 2018, 6:5 DOI: 10.4172/2332-0877.1000378 Research Article Open
More informationRapid detection of carbapenemase-producing Pseudomonas spp.
JCM Accepts, published online ahead of print on 12 September 2012 J. Clin. Microbiol. doi:10.1128/jcm.01597-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Rapid detection
More informationβ-lactamase inhibitors
β-lactamase inhibitors Properties, microbiology & enzymology DAVID M LIVERMORE Professor of Medical Microbiology, UEA Lead on Antibiotic Resistance, Public Health England β-lactamase classes A B C D Serine
More informationDetection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories
REVIEW 10.1111/1469-0691.12678 Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories J. Hrabak, E. Chudackova and C. C. Papagiannitsis Department of
More informationβ- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication
Prevalence of Carbapenem-Hydrolyzing β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication David Alcid M.D Balaji Yegneswaran M.D. Wanpen Numsuwan Introduction Klebsiella pneumoniae
More informationPROFESSOR PETER M. HAWKEY
Multi-drug resistant Escherichia coli PROFESSOR PETER M. HAWKEY School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham Birmingham B15 2TT Health Protection Agency
More informationAMPC BETA LACTAMASES AMONG GRAM NEGATIVE CLINICAL ISOLATES FROM A TERTIARY HOSPITAL, SOUTH INDIA. Mohamudha Parveen R., Harish B.N., Parija S.C.
Brazilian Journal of Microbiology (2010) 41: 596-602 ISSN 1517-8382 AMPC BETA LACTAMASES AMONG GRAM NEGATIVE CLINICAL ISOLATES FROM A TERTIARY HOSPITAL, SOUTH INDIA Mohamudha Parveen R., Harish B.N., Parija
More informationClinical Management of Infections Caused by Enterobacteriaceae that Express Extended- Spectrum β-lactamase and AmpC Enzymes
56 Clinical Management of Infections Caused by Enterobacteriaceae that Express Extended- Spectrum β-lactamase and AmpC Enzymes Patrick N. A. Harris, BSc, MBBS, MRCP, DTM&H, FRACP, FRCPA 1 1 Infection and
More informationAAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac
AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi:10.1128/aac.00931-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationInfectious Disease Testing. UriSelect 4 Medium. Direct Identification Visibly Reliable
Infectious Disease Testing Urielect 4 Medium Direct Identification Visibly Reliable Urielect 4 Non selective chromogenic medium for the isolation, differentiation and enumeration of urinary tract infections
More informationPhenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae
ISSN: 2319-7706 Volume 4 Number 6 (2015) pp. 547-552 http://www.ijcmas.com Original Research Article Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae Sathya Pandurangan 1,
More informationEvaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms
Original Article Clinical Microbiology Ann Lab Med 2017;37:305-312 https://doi.org/10.3343/alm.2017.37.4.305 ISSN 2234-3806 eissn 2234-3814 Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases
More information